Roberts, James E.
Smith, Abigail M.
Wilkerson, Amanda H.
Chandra, Anjali
Patel, Vraj
Quadri, Syed Siraj A.
Mann, Joshua R.
Brodell, Robert T.
Nahar, Vinayak K. http://orcid.org/0000-0002-6771-1662
Article History
Received: 21 January 2020
Revised: 7 February 2020
Accepted: 12 February 2020
First Online: 25 February 2020
Conflict of interest
: Robert Brodell, MD, FAAD, has the following conflicts of interest: Multicenter Clinical Trials: Novartis—Principal Investigator; Corrona Psoriasis Biologic Registry. Editorial Boards: Faculty Advisor, American Medical Student Research Journal; Editor-in-Chief, Practice Update Dermatology; Associate Editor, Journal of the American Academy of Dermatology; Practical Dermatology; Journal of the Mississippi State Medical Society; SKIN: The Journal of Cutaneous Medicine; Archives of Dermatological Research. Advisory Boards: Bracco Diagnostics, Inc. (Gadolinium-based Contrast Agent Litigation); Chairperson of REGN3500 AD independent monitoring committee (iDMC) (Sanofi Genzyme/Regeneron); SunPharma; Cassiopea. There are no conflicts of interest related to employment, stock ownership, expert testimony, grants, patents filed, received, pending, or in preparation, or royalties. James E. Roberts, MD, Abigail M. Smith, BS, Amanda H. Wilkerson, PhD, Anjali Chandra, BS, Vraj Patel, MS, Syed Siraj A. Quadri, PhD, Joshua R. Mann, MD, MPH, Robert T. Brodell, MD, FAAD, and Vinayak K. Nahar, MD, PhD, have no conflicts of interest.